LH - Labcorp Holdings Inc.


220.57
-5.450   -2.471%

Share volume: 701,892
Last Updated: 04-16-2025
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$226.02
-5.45
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
47%
Profitability 53%
Dept financing 31%
Liquidity 21%
Performance 51%
Company vs Stock growth
vs
Performance
5 Days
-3.28%
1 Month
-8.26%
3 Months
-12.50%
6 Months
-12.50%
1 Year
-12.50%
2 Year
-12.50%
Key data
Stock price
$220.57
P/E Ratio 
27.13
DAY RANGE
$219.02 - $226.92
EPS 
$1.72
52 WEEK RANGE
$212.48 - $258.59
52 WEEK CHANGE
-$12.50
MARKET CAP 
20.237 B
YIELD 
0.94%
SHARES OUTSTANDING 
0.000
DIVIDEND
$0.72
EX-DIVIDEND DATE
02-27-2025
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,026,533
AVERAGE 30 VOLUME 
$842,468
Company detail
CEO: Adam H. Schechter
Region: US
Website: labcorp.com
Employees: 75,500
IPO year: 1990
Issue type:
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, and prostate-specific antigens. The company also provides specialty testing services, including gene-based and esoteric testing.

Recent news
loading